MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $470,448 | -75.0% | 10,800 | -79.2% | 0.00% | -75.0% |
| Q2 2023 | $1,878,326 | +100.1% | 51,988 | +105.9% | 0.00% | +100.0% |
| Q1 2023 | $938,869 | -76.9% | 25,252 | -71.9% | 0.00% | -66.7% |
| Q4 2022 | $4,069,654 | +5.3% | 89,818 | +62.3% | 0.01% | -14.3% |
| Q3 2022 | $3,865,000 | -23.7% | 55,332 | -26.7% | 0.01% | +40.0% |
| Q2 2022 | $5,064,000 | -69.7% | 75,442 | -33.8% | 0.01% | -66.7% |
| Q4 2021 | $16,705,000 | +106.2% | 113,880 | +148.6% | 0.02% | +150.0% |
| Q3 2021 | $8,102,000 | -56.9% | 45,800 | -46.5% | 0.01% | -57.1% |
| Q4 2020 | $18,791,000 | +5717.6% | 85,553 | +1937.0% | 0.01% | – |
| Q1 2020 | $323,000 | -65.8% | 4,200 | -42.5% | 0.00% | -100.0% |
| Q4 2019 | $944,000 | -89.8% | 7,310 | -93.9% | 0.00% | -90.0% |
| Q3 2019 | $9,275,000 | -53.6% | 119,054 | -38.6% | 0.01% | -54.5% |
| Q2 2019 | $19,977,000 | +2625.4% | 193,945 | +1839.4% | 0.02% | +2100.0% |
| Q1 2019 | $733,000 | -37.8% | 10,000 | -60.0% | 0.00% | 0.0% |
| Q3 2018 | $1,178,000 | -74.9% | 25,000 | -73.7% | 0.00% | -83.3% |
| Q2 2018 | $4,684,000 | +117000.0% | 95,000 | +27042.9% | 0.01% | – |
| Q3 2017 | $4,000 | -33.3% | 350 | -78.1% | 0.00% | – |
| Q2 2017 | $6,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |